Hi, everyone, i am a fresher of tumor immunology.

Recently, i am preparing to study how pdl1 regulation in tumor cells will affect the function of t cells. and i have read a paper " miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint. Nat Commun" . In this paper, author applied PBMC from healthy human with the anti-CD3, anti-CD28 and incubation of skov3 tumor lysates. Then, isolated CD8 T cells to co-culture with skov3 cells. i would like to apply this model, but i have a question, anti-CD3 and anti-CD28 has made CD8+ T cells activated, why do they need to add tumor lysates?

And, right now, i don't make sure whether i should apply antigen-specific CD8+T cells to coculture with tumor cells? other papers indicated that firstly isolated monocyte-derived DC and then make them matured with some cytokine stimulation and tumor lysates incubation. Then matured DC cocultured with CD8+ T cells to get the tumor-antigen specific T cells. These obtained CD8 T cells then cocultured with tumor cell lines. could you kindly give me some advice based on my research purpose?

More Jiangnan He's questions See All
Similar questions and discussions